...
机译:Myopalladin突变导致遗传性心肌病临床异质性的分子基础
1The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA, 2Department of Molecular Pathogenesis, Medical Research Institute and Laboratory of Genome Diversity, Tokyo Medical and Dental University, Tokyo, Japan, 3Department of Medicine, 4Department of Pediatrics and 5Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA, 6Department of Medicine, Tokyo Women's Medical University, Tokyo, Japan, 7Department of Pediatrics, Section of Pathology, Baylor College of Medicine, Houston, TX, USA, 8Third Department of Medicine, Osaka Medical College, Takatsuki, Japan, 9Department of Cardiology, The Heart Hospital, London, UK, 10Department of Experimental Medicine, Klinikum Mannheim, Mannheim, Germany,
机译:Myopalladin突变导致遗传性心肌病临床异质性的分子基础
机译:母体遗传性肥厚性心肌病:线粒体DNA突变的表现—两个家庭的临床过程
机译:遗传性钙通道病的分子基础:突变在成孔亚基中的作用
机译:犬类遗传性出血障碍的临床病理/分子基础
机译:对遗传性心律失常和遗传性心肌病基因的不确定意义变异的评估和对临床实践的评价
机译:Myopalladin突变导致遗传性心肌病临床异质性的分子基础
机译:由于肌神经蛋白突变,遗传性心肌病的临床异质性分子基础